NASDAQ: ALLR
Allarity Therapeutics Inc Stock Ownership - Who owns Allarity Therapeutics?

Insider buying vs selling

Have Allarity Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Jeremy R. GraffPresident and Chief Development Officer2025-09-3014,613$1.58
$23.09kSell

1 of 1

ALLR insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ALLR insiders and whales buy or sell their stock.

ALLR Shareholders

What type of owners hold Allarity Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Leon Sass6.83%1,086,238$1.42MInsider
Thomas Jensen3.75%596,734$781.72kInsider
Jeremy R. Graff2.40%381,644$499.95kInsider
Renaissance Technologies LLC1.43%228,084$298.79kInstitution
Geode Capital Management LLC1.20%190,393$249.41kInstitution
Vanguard Capital Management LLC1.08%171,795$225.05kInstitution
Jeffrey S. Ervin0.94%150,000$196.50kInsider
State Street Corp0.86%137,600$180.26kInstitution
Steen Knudsen0.79%124,976$163.72kInsider
Alexander Epshinsky0.53%85,051$111.42kInsider

1 of 3

ALLR vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ALLR5.97%16.02%Net Selling
ELOX0.00%100.00%Net Buying
CELU2.18%97.82%Net Selling
NEUP20.40%79.60%Net Buying
CTXR3.63%2.06%

Allarity Therapeutics Stock Ownership FAQ

Who owns Allarity Therapeutics?

Allarity Therapeutics (NASDAQ: ALLR) is owned by 5.97% institutional shareholders, 16.02% Allarity Therapeutics insiders, and 78.00% retail investors. Leon Sass is the largest individual Allarity Therapeutics shareholder, owning 1.09M shares representing 6.83% of the company. Leon Sass's Allarity Therapeutics shares are currently valued at $1.44M.

If you're new to stock investing, here's how to buy Allarity Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.